303 related articles for article (PubMed ID: 23894455)
1. Surface α-enolase promotes extracellular matrix degradation and tumor metastasis and represents a new therapeutic target.
Hsiao KC; Shih NY; Fang HL; Huang TS; Kuo CC; Chu PY; Hung YM; Chou SW; Yang YY; Chang GC; Liu KJ
PLoS One; 2013; 8(7):e69354. PubMed ID: 23894455
[TBL] [Abstract][Full Text] [Related]
2. Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells.
Principe M; Ceruti P; Shih NY; Chattaragada MS; Rolla S; Conti L; Bestagno M; Zentilin L; Yang SH; Migliorini P; Cappello P; Burrone O; Novelli F
Oncotarget; 2015 May; 6(13):11098-113. PubMed ID: 25860938
[TBL] [Abstract][Full Text] [Related]
3. Alpha-enolase plasminogen receptor in myogenesis.
Lopez-Alemany R; Suelves M; Diaz-Ramos A; Vidal B; Munoz-Canoves P
Front Biosci; 2005 Jan; 10():30-6. PubMed ID: 15574344
[TBL] [Abstract][Full Text] [Related]
4. Seahorse-derived peptide suppresses invasive migration of HT1080 fibrosarcoma cells by competing with intracellular α-enolase for plasminogen binding and inhibiting uPA-mediated activation of plasminogen.
Kim YT; Kim SK; Jeon YJ; Park SJ
BMB Rep; 2014 Dec; 47(12):691-6. PubMed ID: 24602611
[TBL] [Abstract][Full Text] [Related]
5. Enolase-1 promotes plasminogen-mediated recruitment of monocytes to the acutely inflamed lung.
Wygrecka M; Marsh LM; Morty RE; Henneke I; Guenther A; Lohmeyer J; Markart P; Preissner KT
Blood; 2009 May; 113(22):5588-98. PubMed ID: 19182206
[TBL] [Abstract][Full Text] [Related]
6. Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis.
Principe M; Borgoni S; Cascione M; Chattaragada MS; Ferri-Borgogno S; Capello M; Bulfamante S; Chapelle J; Di Modugno F; Defilippi P; Nisticò P; Cappello P; Riganti C; Leporatti S; Novelli F
J Hematol Oncol; 2017 Jan; 10(1):16. PubMed ID: 28086938
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-Enolase.
López-Alemany R; Longstaff C; Hawley S; Mirshahi M; Fábregas P; Jardí M; Merton E; Miles LA; Félez J
Am J Hematol; 2003 Apr; 72(4):234-42. PubMed ID: 12666133
[TBL] [Abstract][Full Text] [Related]
8. Transforming Growth Factor-Beta and Urokinase Type Plasminogen Interplay in Cancer.
Santibanez JF; Krstic J
Curr Protein Pept Sci; 2018; 19(12):1155-1163. PubMed ID: 29086689
[TBL] [Abstract][Full Text] [Related]
9. The nine residue plasminogen-binding motif of the pneumococcal enolase is the major cofactor of plasmin-mediated degradation of extracellular matrix, dissolution of fibrin and transmigration.
Bergmann S; Rohde M; Preissner KT; Hammerschmidt S
Thromb Haemost; 2005 Aug; 94(2):304-11. PubMed ID: 16113819
[TBL] [Abstract][Full Text] [Related]
10. Alpha-Enolase (
Cappello P; Principe M; Bulfamante S; Novelli F
Front Biosci (Landmark Ed); 2017 Jan; 22(5):944-959. PubMed ID: 27814656
[TBL] [Abstract][Full Text] [Related]
11. Plasmin generation dependent on alpha-enolase-type plasminogen receptor is required for myogenesis.
López-Alemany R; Suelves M; Muñoz-Cánoves P
Thromb Haemost; 2003 Oct; 90(4):724-33. PubMed ID: 14515195
[TBL] [Abstract][Full Text] [Related]
12. Enolase of Mycobacterium tuberculosis is a surface exposed plasminogen binding protein.
Rahi A; Matta SK; Dhiman A; Garhyan J; Gopalani M; Chandra S; Bhatnagar R
Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3355-3364. PubMed ID: 27569900
[TBL] [Abstract][Full Text] [Related]
13. Silencing of ENO1 by shRNA Inhibits the Proliferation of Gastric Cancer Cells.
Qiao H; Wang YF; Yuan WZ; Zhu BD; Jiang L; Guan QL
Technol Cancer Res Treat; 2018 Jan; 17():1533033818784411. PubMed ID: 29986635
[TBL] [Abstract][Full Text] [Related]
14. uPA and uPAR contribute to NK cell invasion through the extracellular matrix.
Al-Atrash G; Kitson RP; Xue Y; Mazar AP; Kim MH; Goldfarb RH
Anticancer Res; 2001; 21(3B):1697-704. PubMed ID: 11497249
[TBL] [Abstract][Full Text] [Related]
15. CS5931, A Novel Marine Polypeptide, Inhibits Migration and Invasion of Cancer Cells Via Interacting with Enolase 1.
Su S; Xu H; Chen X; Qiao G; Farooqi AA; Tian Y; Yuan R; Liu X; Li C; Li X; Wu N; Lin X
Recent Pat Anticancer Drug Discov; 2018; 13(3):360-367. PubMed ID: 29956637
[TBL] [Abstract][Full Text] [Related]
16. A hybrid protein comprising ATF domain of pro-UK and VAS, an angiogenesis inhibitor, is a potent candidate for targeted cancer therapy.
Sun Q; Xu Q; Dong X; Cao L; Huang X; Hu Q; Hua ZC
Int J Cancer; 2008 Aug; 123(4):942-50. PubMed ID: 18528863
[TBL] [Abstract][Full Text] [Related]
17. Alpha-enolase is upregulated on the cell surface and responds to plasminogen activation in mice expressing a ∆133p53α mimic.
Sawhney S; Hood K; Shaw A; Braithwaite AW; Stubbs R; Hung NA; Royds JA; Slatter TL
PLoS One; 2015; 10(2):e0116270. PubMed ID: 25643152
[TBL] [Abstract][Full Text] [Related]
18. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vitro: correlation with metastatic behavior in vivo.
Quax PH; de Bart AC; Schalken JA; Verheijen JH
Prostate; 1997 Aug; 32(3):196-204. PubMed ID: 9254899
[TBL] [Abstract][Full Text] [Related]
20. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
